Literature DB >> 19656986

Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.

Nereida Jiménez de Oya1, Inmaculada Galindo, Olivia Gironés, Erwin Duizer, José M Escribano, Juan-Carlos Saiz.   

Abstract

Hepatitis E virus (HEV) is a major cause of acute hepatitis in humans, and strains of genotypes 1 and 2 are endemic in many regions with suboptimal sanitary conditions. In many industrialized countries, HEV strains of genotype 3 are highly endemic in swine, and an increased number of autochthonous infections with HEV genotype 3 strains have been reported lately. Serological studies of HEV infection are often conducted with commercial assays based on peptides and recombinant proteins of HEV genotype 1 and 2 strains. For some patients with proven HEV genotype 3 infections, these assays failed to detect specific antibodies, and they are not applicable or validated for the detection of anti-HEV antibodies in swine. To elucidate the incidence of hepatitis E in regions where HEV genotype 3 infections can be expected, and to study the seroprevalence of HEV in swine, new tools with broad specificity for all genotypes of HEV are needed. We present the expression and partial characterization of recombinant HEV genotype 3 open reading frame 2 (ORF-2) proteins and their usefulness as diagnostic antigens in detecting anti-HEV antibodies in humans and swine with proven HEV genotype 3 infections. The recombinant antigens were produced at relatively high yields and at low cost upon infection of Trichoplusia ni larvae with recombinant baculoviruses expressing recombinant HEV genotype 3 ORF-2 proteins. The enzyme-linked immunosorbent assay based on the recombinant proteins showed good specificity and sensitivity for anti-HEV genotype 3 immunoglobulin G detection in human and swine sera. These recombinant HEV genotype 3 ORF-2 proteins might be added to diagnostic kits containing HEV genotype 1 and 2 antigens in order to develop a broadly sensitive new tool for the diagnosis of hepatitis E.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656986      PMCID: PMC2756903          DOI: 10.1128/JCM.00750-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar.

Authors:  Hiroyuki Matsuda; Katsuo Okada; Kazuaki Takahashi; Shunji Mishiro
Journal:  J Infect Dis       Date:  2003-09-15       Impact factor: 5.226

2.  Serodiagnosis of African swine fever using the recombinant protein p30 expressed in insect larvae.

Authors:  M G Barderas; A Wigdorovitz; F Merelo; F Beitia; C Alonso; M V Borca; J M Escribano
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

3.  Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis.

Authors:  J Z Zhang; Stanley W K Im; S H Lau; T N Chau; S T Lai; S P Ng; Malik Peiris; Cindy Tse; T K Ng; M H Ng
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

Review 4.  Hepatitis E: an overview.

Authors:  Harald C Worm; Wim H M van der Poel; Gerald Brandstätter
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

5.  Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food.

Authors:  Yasuyuki Yazaki; Hitoshi Mizuo; Masaharu Takahashi; Tsutomu Nishizawa; Nobuhiko Sasaki; Yuhko Gotanda; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

Review 6.  Swine hepatitis E virus: cross-species infection and risk in xenotransplantation.

Authors:  X J Meng
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

Review 7.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

8.  Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands.

Authors:  Marc-Alain Widdowson; Wim J M Jaspers; Wim H M van der Poel; Froukje Verschoor; Ana Maria de Roda Husman; H L J Winter; Hans L Zaaijer; Marion Koopmans
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

9.  Zoonotic transmission of hepatitis E virus from deer to human beings.

Authors:  Shuchin Tei; Naoto Kitajima; Kazuaki Takahashi; Shunji Mishiro
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

10.  Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands.

Authors:  W H van der Poel; F Verschoor; R van der Heide; M I Herrera; A Vivo; M Kooreman; A M de Roda Husman
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  15 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Diagnosis of hepatitis E.

Authors:  Rakesh Aggarwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

3.  Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States.

Authors:  Chen Dong; Jihong Meng; Xing Dai; Jiu-Hong Liang; Alicia R Feagins; Xiang-Jin Meng; Natalia M Belfiore; Carol Bradford; Joseph L Corn; Carolyn Cray; Gregory E Glass; Melvin L Gordon; Richard A Hesse; Donald L Montgomery; William L Nicholson; Anthony A Pilny; Sheela Ramamoorthy; Douglas D Shaver; Jan Drobeniuc; Michael A Purdy; Howard A Fields; Saleem Kamili; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

4.  Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.

Authors:  Paul Dremsek; Jürgen J Wenzel; Reimar Johne; Mario Ziller; Jörg Hofmann; Martin H Groschup; Sandra Werdermann; Ulrich Mohn; Silvia Dorn; Manfred Motz; Marc Mertens; Wolfgang Jilg; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2011-12-18       Impact factor: 3.402

Review 5.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

6.  A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus.

Authors:  Jiu-Hong Liang; Xing Dai; Chen Dong; Ji-Hong Meng
Journal:  Int J Mol Sci       Date:  2010-08-12       Impact factor: 5.923

7.  Prevalence of Hepatitis E Virus (HEV) Antibodies in Mexican Pigs.

Authors:  Teresa Merino-Ramos; Miguel A Martín-Acebes; Jordi Casal; Juan-Carlos Saiz; Elizabeth Loza-Rubio
Journal:  Food Environ Virol       Date:  2016-02-15       Impact factor: 2.778

8.  Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.

Authors:  Felicitat Todolí; Alhelí Rodríguez-Cortés; María Del Carmen Núñez; Márcia D Laurenti; Silvia Gómez-Sebastián; Fernando Rodríguez; Eva Pérez-Martín; José M Escribano; Jordi Alberola
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Widespread distribution of hepatitis E virus in Spanish pig herds.

Authors:  Nereida Jiménez de Oya; Ignacio de Blas; Ana-Belén Blázquez; Miguel A Martín-Acebes; Nabil Halaihel; Olivia Gironés; Juan-Carlos Saiz; Estela Escribano-Romero
Journal:  BMC Res Notes       Date:  2011-10-14

10.  Use of immuno-dominant epitope derived from genotype 4 as a diagnostic reagent for detecting the antibodies against Hepatitis E Virus.

Authors:  Bing-shui Xiu; Xiao-yan Feng; Jing He; Kun Chen; Jing Liu; Zhen-hua Dai; Xi-qin Yang; Guo-hua Wang; You-chun Wang; He-qiu Zhang; Xiao-guo Song; Cui-xia Zhu
Journal:  Virol J       Date:  2013-04-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.